A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patients
Clinical trial NCT06521931 · COMPLETED
Trial details
- NCT number
- NCT06521931
- Sponsor
- Chongqing Peg-Bio Biopharm Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-06
- Primary completion
- 2025-01-13
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.